NCT02032745View on ClinicalTrials.gov

Genomic Signatures to Predict Treatment Response

CompletedOBSERVATIONAL
Enrollment

277

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Breast Neoplasms
Trial Locations (1)

8036

Institute of Pathology, Med. Univ. Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT02032745 - Genomic Signatures to Predict Treatment Response | Biotech Hunter | Biotech Hunter